Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Prophylactic Penehyclidine Hydrochloride Inhalation on Long-term Outcome in High-risk Patients: 3-year Follow-up of a Randomized Controlled Trial

NCT03868709 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT03868709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03868709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Prophylactic Penehyclidine Hydrochloride Inhalation on Long-term Outcome in High-risk Patients: 3-year Follow-up of a Randomized Controlled Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 12, 2019
Completion date
December 1, 2021
Enrollment
864 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long-term outcome, postoperative complications